Trusted Digital Patient Information for Safer Medication Use

Rote Liste® helps pharmaceutical companies in Germany provide regulatory-compliant patient information while ensuring that patients have access to reliable, accessible, and up-to-date information. 

Increased Visibility and Presence for Your Patient Information Through Trusted Rote Liste Channels

By using our digital solutions, you ensure that patients can easily find and access your information at any time. We make this possible through accessible formats, dedicated websites, and mobile application.

Your Patient Information on Rote Liste: Key Benefits

Accessible Formats

Content provided in accessible formats to support blind and visually impaired individuals.

Easy Access

Informationen sind jederzeit per Website oder App abrufbar.

Always Up-to-Date

Approved updates are published digitally and become available immediately. 

Safe & Easy to Understand

A clear structure, improved readability, and additional features help enhance patient safety.
Screenshot der Startseite von GI 4.0

GI 4.0® (Electronic Package Leaflet)

Digital Patient Information for Modern, Compliant Patient Communication

GI 4.0 provides pharmaceutical companies with an established ePI solution for making regulatory-approved patient information available digitally, up-to-date, and easily accessible to patients. The platform supports the regulatory implementation of ePI and offers a direct communication channel to patients through web and app access. The information is always available, advertising-free, and in accessible formats. Features such as adjustable font sizes, intuitive search functionality, and easy access via DMC/barcode scanning improve accessibility and usability. The integration of educational materials, update notifications, and batch-specific information further contributes to medication safety. GI 4.0 is a proven, future-ready solution for the digital distribution of patient information leaflets, ready for the next generation of pharmaceutical communication.

GI 4.0 is the technological foundation of the diGItal Project, supporting the implementation of digital patient information in line with the EU Pharmaceutical Package.

+

Searches

The search function for Patient Information Leaflet is used more than 45,000 times a year.

+

Downloads

More than 180,000 Patient Information Leaflets are downloaded annually in PDF format.

+

Audio Reads

Patients use the text-to-speech function more than 22,000 times a year.

Screenshot der Startseite von Patienteninfo-Service

Rote Liste® PatientenInfo-Service (Patient Info Service)

Accessible Patient Information Leaflets for Blind and Visually Impaired Patients

Developed in close cooperation with the German Federation of the Blind and Partially Sighted, the PatientenInfo-Service provides patient information leaflets for blind and visually impaired individuals in accordance with Section 11 (3c) of the German Medicines Act. The service ensures that patients can access essential medication information regardless of their individual needs. The patient information leaflet is provided in various formats, including a high-contrast website, accessible PDF documents, and downloadable HTML formats optimized for screen readers and text-to-speech applications, ensuring information is easy to access and understand. 

Our Customers

More than 500 Customers Trust Our Solutions

Screenshot 2025-10-20 103813

Integration into Your Corporate Website

Website Widget for SmPC and Patient Information Directly on Your Website

The Rote Liste® Website Widget enables you to integrate both SmPC and patient information directly into your own website in HTML format, allowing users to access information without leaving your corporate website.
The content is automatically synchronized whenever updated versions are approved and published on our platforms. This allows you to maintain full control over website traffic while ensuring compliance with all applicable regulatory requirements.

Newsletter

Stay informed

Subscribe to our newsletter for pharmaceutical companies to receive regular updates from Rote Liste.

What Our Customers Say About Us

Eisai would like to support patients, their relatives, and healthcare professionals as effectively as possible with up‑to‑date product information texts before and during therapy with our medicinal products. 

Using the various services offered by Rote Liste brings us one step closer to this goal. 

Dr. Daniela Gschwend 
Medical Director 
Eisai GmbH 

The collaboration with Rote Liste offers significant value for us as a pharmaceutical company: validated information enhances patient safety, reaches target groups quickly across broad analogue and digital channels, and is accessible without barriers. 
Standardized data formats and interfaces also enable seamless integration into digital health applications.

This combination of trust, reach, and digital strength makes the partnership especially valuable.

MSD Sharp & Dohme GmbH

Up-to-date package leaflets for patients and medicines information for healthcare specialists, along with easy handling for us – great! 

Dr. Nora Beutelmann,
Director Medical Affairs
Dr. Wilmar Schwabe GmbH & Co. KG